2.69
0.00 (0.0%)
0.00 (0.0%)
Upgrade to Real-Time
Afterhours (Closed)
Best deals to access real time data! |
|
Ultimate Trader (Monthly)
Monthly Subscription
for only
|
|
Small Cap Basic
Monthly Subscription
for only
|
|
Big Cap Pro
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| AIM ImmunoTech Inc | AIM | AMEX | Common Stock |
| Price Change | Change Percent | Stock Price | Low Price | High Price | Open Price | Close Price | Last Traded  |
|
|---|---|---|---|---|---|---|---|---|
| -0.09 | -3.24% | 2.69 | 2.55 | 2.73 | 2.69 | 2.78 | 20:00:00 |
| Stock Trades | Traded Volume | VWAP | Dollar Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 7,851 | 2,964,773 | $ 2.62 | $ 7,766,450 | 4,012,178 | 0.381 - 8.75 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 20:00:00 | 4,353 | $ 2.69 | USD |
AIM ImmunoTech Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 78.51M | 29.19M | 18.14M | $ 140.00k | $ - | -9.56 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| 1.38M | $ - | 0.00% | 24.00 | 37.40% |
AIM ImmunoTech News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical AIM Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 2.43 | 3.11 | 2.22 | 2.69 | 4,643,169 | 0.26 | 10.7% |
| 1 Month | 2.15 | 3.47 | 1.95 | 2.64 | 5,042,298 | 0.54 | 25.12% |
| 3 Months | 5.25 | 8.02 | 1.75 | 2.74 | 5,505,974 | -2.56 | -48.76% |
| 6 Months | 0.4198 | 8.75 | 0.3877 | 2.90 | 5,675,128 | 2.27 | 540.78% |
| 1 Year | 1.96 | 8.75 | 0.381 | 2.82 | 3,964,950 | 0.73 | 37.24% |
| 3 Years | 1.96 | 8.75 | 0.381 | 2.82 | 3,964,950 | 0.73 | 37.24% |
| 5 Years | 1.96 | 8.75 | 0.381 | 2.82 | 3,964,950 | 0.73 | 37.24% |
AIM ImmunoTech Description
| AIM ImmunoTech Inc is a US-based specialty pharmaceutical company. It is engaged in the clinical development of drug therapies based on natural immune system enhancing technologies for the treatment of viral and immune-based disorders. The products of the firm are Alferon N Injection and the experimental therapeutic Ampligen. Alferon N Injection is approved for a category of STD infection, and Ampligen represents a RNA being developed for viral diseases and disorders of the immune system. The sales revenue of the company is derived from the United States. |
